Evidence Hub

Atypical Fibroxanthoma/Pleomorphic Dermal Sarcoma With Osseous Metaplasia: A Series of Three Cases

Novice T, Xu Y, Brenn T, Bresler SC

Journal of cutaneous pathology, 2026

Abstract

Atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) are rare mesenchymal tumors typically arising on sun-damaged skin of the head and neck in elderly patients. PDS is a more aggressive tumor but with similar demographics, cellular morphology, immunohistochemical features, and genetic findings. The histopathologic diversity and lack of specific immunohistochemical markers for these entities increase the risk of misdiagnosis. To our knowledge, osteoid matrix production has been noted previously in only one case of PDS. We present three additional cases of AFX/PDS with osseous metaplasia, all of which were from the head of elderly patients (91-93 years old). No case recurred or metastasized, thus underscoring the importance of distinguishing this entity from other primary or metastatic tumors with osseous differentiation or metaplasia.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free